Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients

NCT01395056 · clinicaltrials.gov ↗
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Peking University Cancer Hospital & Institute